Recent Research Funding

Our faculty secure major research grants from various National Institutes of Health as well as private sources.

  • Molecular Physiology of NMDA Receptors. Gabriela Popescu (Principal Investigator). NINDS. $4,200,000. 5/1/2023-4/1/2031.
  • Molecular Mechanisms of Severe Diabetic Retinopathy. Sarah Zhang (Principal Investigator). National Eye Institute/NIH. $2,374,855. 9/1/2024-5/1/2029.
  • MRI-Based Quantitative Mapping of Oxygen Extraction Fraction in MS. Ferdinand Schweser (Co-Investigator). NIBIB. $1,773,283. 4/1/2024-3/1/2029.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Michael Duffey (Co-Investigator). NIH National Eye Institute. $1,972,804. 2/1/2018-9/1/2028.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Mark Parker (Principal Investigator). NIH National Eye Institute. 1/1/2018-9/1/2028.
  • A Multifactorial Mechanism for Alzheimer’s Disease. Zhen Yan (Principal Investigator). VA. $1,115,372. 10/1/2024-9/1/2028.
  • The Role of the Bed Nucleus of the Stria Terminalis-Norepinephrine System in Amphetamine-type Stimulant Use Disorders. Jinwoo Park (Principal Investigator). NIH/NIDA. $3,225,662. 9/1/2023-6/1/2028.
  • Novel Inhibitors of Lysine Methyltransferases G9a and GLP for the Treatment of Alzheimer's Disease. Zhen Yan (Co-Investigator). NIA/NIH. $3,309,300. 9/1/2023-6/1/2028.
  • Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease. Fraser Sim (Co-Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $2,930,725. 7/1/2023-6/1/2028.
  • Regulatory mechanisms for retinal ganglion cell genesis. Xiuqian Mu (Principal Investigator). National Eye Institute. $2,311,139. 8/1/2023-4/1/2028.
  • Investigating the Action and Physiological Role of Slc4a11 in the Cornea. Sangita Patel (Co-Investigator). NIH National Eye Institute. $3,944,767. 2/1/2018-1/1/2028.
  • Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells. Zhen Yan (Principal Investigator). NINDS/NIH. $3,088,565. 2/1/2023-1/1/2028.
  • Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells. Jian Feng (Principal Investigator). NINDS. $1,544,283. 2/1/2023-1/1/2028.
  • A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). VA Central Office. $330,000. 1/1/2025-12/1/2027.
  • Exercise Reset for Concussion - Modifying the Buffalo Concussion Protocol for Application in a Military Environment. John Leddy (Principal Investigator). Department of Defense (CDMRP). 1/1/2023-12/1/2027.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,993,750. 12/1/2021-11/1/2027.
  • Transcriptomic and Circuitry Aberrations in Alzheimer’s Disease. Zhen Yan (Principal Investigator). NIA/NIH. $3,710,395. 12/1/2022-11/1/2027.
  • Transcriptomic and Circuitry Aberrations in Alzheimer’s Disease. Jian Feng (Principal Investigator). NIA. $1,855,198. 12/1/2022-11/1/2027.
  • Injuries of the corneal endothelium. Sangita Patel (Principal Investigator). Department of Veterans Affairs, Biomedical Laboratory Research and Development. $543,160. 10/1/2023-9/1/2027.
  • “Injuries of the Corneal Endothelium”. Steven Fliesler (Co-Investigator). VA. $543,160. 10/1/2023-9/1/2027.